QTRX (STOCKS)
Quanterix Corporation Common Stock
$3.390000
+0.030000 (+0.89%)
Prev close: $3.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Everett V. Cunningham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $158.89M
- Employees
- 136
- P/E (TTM)
- -1.33
- P/B (TTM)
- 0.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
6
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.49 | $-0.46 | -0.0310 | -6.75% |
|
Sep 2025 (Q3)
|
$-0.73 | $-0.54 | -0.1894 | -35.04% |
|
Jun 2025 (Q2)
|
$-0.57 | $-0.37 | -0.2028 | -55.23% |
|
Mar 2025 (Q1)
|
$-0.42 | $-0.45 | +0.0254 | +5.70% |
Financial Statements
| Revenues | $138.90M |
| Benefits Costs and Expenses | $251.17M |
| Cost Of Revenue | $73.94M |
| Costs And Expenses | $251.17M |
| Gross Profit | $64.96M |
| Operating Expenses | $190.50M |
| Selling, General, and Administrative Expenses | $138.01M |
| Research and Development | $35.92M |
| Other Operating Expenses | $16.57M |
| Operating Income/Loss | -$125.54M |
| Income/Loss From Continuing Operations After Tax | -$107.15M |
| Income/Loss From Continuing Operations Before Tax | -$112.27M |
| Income Tax Expense/Benefit | -$5.12M |
| Income Tax Expense/Benefit, Current | $509.00K |
| Income Tax Expense/Benefit, Deferred | -$5.63M |
| Interest Income/Expense After Provision For Losses | $7.10M |
| Interest Income/Expense Operating, Net | $8.57M |
| Net Income/Loss | -$107.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$107.15M |
| Net Income/Loss Available To Common Stockholders, Basic | -$107.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $1.47M |
| Basic Earnings Per Share | -$2.51 |
| Diluted Earnings Per Share | -$2.51 |
| Basic Average Shares | 42,639,000 |
| Diluted Average Shares | 42,639,000 |
| Assets | $418.77M |
| Current Assets | $212.26M |
| Inventory | $54.76M |
| Other Current Assets | $157.49M |
| Noncurrent Assets | $206.51M |
| Fixed Assets | $23.67M |
| Intangible Assets | $131.79M |
| Other Non-current Assets | $51.05M |
| Liabilities | $123.04M |
| Current Liabilities | $74.76M |
| Accounts Payable | $13.57M |
| Other Current Liabilities | $61.19M |
| Noncurrent Liabilities | $48.27M |
| Equity | $295.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $295.73M |
| Liabilities And Equity | $418.77M |
| Net Cash Flow From Operating Activities | -$77.24M |
| Net Cash Flow From Operating Activities, Continuing | -$77.24M |
| Net Cash Flow From Investing Activities | $50.23M |
| Net Cash Flow From Investing Activities, Continuing | $50.23M |
| Net Cash Flow From Financing Activities | -$708.00K |
| Net Cash Flow From Financing Activities, Continuing | -$708.00K |
| Exchange Gains/Losses | $1.57M |
| Net Cash Flow | -$26.14M |
| Net Cash Flow, Continuing | -$27.71M |
| Comprehensive Income/Loss | -$104.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$104.79M |
| Other Comprehensive Income/Loss | $2.36M |
| Other Comprehensive Income/Loss Attributable To Parent | $2.36M |